FreeCME

Medical Crossfire®: Hot Topics in Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors (PCSK9i)

CME: 1.5

February 12, 2019
/ Print / Reprints /
| Share More
/ Text Size+

Post a comment to this article